ACADIA Pharmaceuticals Inc. (ACAD) Social Stream



ACADIA Pharmaceuticals Inc. (ACAD): $21.69

0.31 (+1.45%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add ACAD to Watchlist
Sign Up

ACADIA PHARMACEUTICALS INC (ACAD) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ACADIA PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 17 $35 $18 $25.125 $22.85 9.96%
2021-12-07 17 $35 $18 $25.562 $22.85 11.87%
2021-12-08 18 $35 $18 $26.562 $22.85 16.25%
2021-12-09 18 $39 $18 $27.235 $22.85 19.19%
2021-12-21 18 $39 $18 $27.588 $22.85 20.74%
2021-12-22 19 $42 $18 $28.777 $22.85 25.94%
2022-01-28 19 $42 $18 $28.944 $22.85 26.67%
2022-02-09 19 $42 $20 $29.944 $22.85 31.05%
2022-03-02 19 $42 $20 $29.777 $22.85 30.32%
2022-03-10 19 $42 $20 $30.055 $22.85 31.53%
2022-04-03 19 $42 $20 $30.111 $22.85 31.78%
2022-04-19 18 $42 $20 $30.111 $22.85 31.78%
2022-04-26 18 $42 $20 $30.166 $22.85 32.02%
2022-05-06 18 $42 $20 $29.833 $22.85 30.56%
2022-06-08 18 $42 $20 $29.882 $22.85 30.77%
2022-06-15 17 $42 $20 $29.882 $22.85 30.77%
2022-06-16 17 $42 $20 $30.058 $22.85 31.54%
2022-06-21 17 $42 $20 $29.411 $22.85 28.71%
2022-08-01 17 $42 $10 $24.437 $22.85 6.95%
2022-08-02 17 $42 $10 $24.117 $22.85 5.54%
2022-08-05 17 $42 $10 $24 $22.85 5.03%
2022-08-08 17 $42 $10 $23.062 $22.85 0.93%
2022-08-09 19 $42 $10 $22.411 $22.85 -1.92%
2022-08-10 19 $42 $10 $21.294 $22.85 -6.81%
2022-09-17 19 $42 $10 $20.764 $22.85 -9.13%
2022-10-03 18 $42 $10 $20.764 $22.85 -9.13%
2022-10-13 18 $42 $10 $20.647 $22.85 -9.64%
2022-10-21 17 $42 $10 $20.647 $22.85 -9.64%
2022-11-01 18 $42 $10 $20.444 $22.85 -10.53%
2022-11-04 19 $42 $10 $20.388 $22.85 -10.77%
2022-11-07 19 $42 $10 $20.333 $22.85 -11.02%
2022-11-15 19 $42 $10 $20.222 $22.85 -11.5%
2022-12-13 18 $42 $10 $20.222 $22.85 -11.5%
2022-12-21 18 $25 $10 $18.25 $22.85 -20.13%
2023-01-03 18 $25 $10 $18.47 $22.85 -19.17%
2023-01-25 18 $25 $10 $18.529 $22.85 -18.91%
2023-01-27 18 $25 $10 $18.529 $22.85 -18.91%
2023-01-30 18 $27 $10 $18.647 $22.85 -18.39%
2023-01-31 18 $27 $10 $18.764 $22.85 -17.88%
2023-02-08 18 $25 $10 $18.705 $22.85 -18.14%
2023-02-13 18 $27 $10 $18.823 $22.85 -17.62%
2023-02-27 18 $27 $10 $18.882 $22.85 -17.37%
2023-02-28 18 $28 $10 $19.058 $22.85 -16.6%
2023-03-01 19 $28 $10 $20.022 $22.85 -12.38%
2023-03-03 19 $28 $10 $20.188 $22.85 -11.65%
2023-03-06 19 $28 $10 $20.3 $22.85 -11.16%
2023-03-13 19 $28 $10 $20.633 $22.85 -9.7%
2023-03-14 19 $33 $12 $21.911 $22.85 -4.11%
2023-05-09 18 $33 $12 $22.244 $22.85 -2.65%
2023-05-10 18 $33 $12 $22.244 $22.85 -2.65%
2023-05-19 18 $33 $12 $22.422 $22.85 -1.87%
2023-06-06 18 $33 $12 $22.588 $22.85 -1.15%
2023-06-15 18 $36 $12 $23.588 $22.85 3.23%
2023-07-11 17 $36 $12 $24.152 $22.85 5.7%
2023-07-14 17 $36 $12 $24.447 $22.85 6.99%
2023-07-17 17 $42 $12 $27.8 $22.85 21.66%
2023-07-28 17 $42 $12 $28.882 $22.85 26.4%
2023-08-03 17 $42 $12 $29.411 $22.85 28.71%
2023-08-14 17 $42 $12 $29.47 $22.85 28.97%
2023-10-08 17 $42 $12 $30.062 $22.85 31.56%
2023-10-10 17 $42 $12 $30.25 $22.85 32.39%
2023-10-17 17 $42 $12 $30.125 $22.85 31.84%
2023-11-03 17 $42 $13 $31.187 $22.85 36.49%
2023-11-06 17 $42 $13 $31.125 $22.85 36.21%
2023-11-16 17 $42 $13 $31.437 $22.85 37.58%

The Trend in the Analyst Price Target


ACAD's average price target has moved up $4.12 over the prior 28 months.

ACAD reports an average of 7.01% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-12-13 18 42 10 20.222 15.82 27.83%
2023-02-08 18 25 10 18.705 19.72 -5.15%
2023-03-13 19 28 10 20.633 19.41 6.3%
2023-03-14 18 33 12 21.688 20.38 6.42%
2023-04-05 18 33 12 22.244 18.28 21.68%

ACAD Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 9 1 6 1 1 17

The Trend in the Broker Recommendations


ACAD's average broker recommendation rating improved by 0.47 over the prior 35 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • ACADIA PHARMACEUTICALS INC's number of analysts covering the stock is greater than 6773.67% of all US stocks.
  • ACADIA PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1007.24% of Pharmaceutical Products stocks.
  • In terms of how ACADIA PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -6536.03% of that group.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, ACADIA PHARMACEUTICALS INC's average analyst price target is higher than 2722.89% of them.

Stocks similar to ACADIA PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PTCT, SAVA, and CYTK.

What is the outlook for ACAD? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!